Option Care Health, Inc. (OPCH) Key Metrics
OPCH valuation today
Trailing 12 months · as of October 18, 2026- Market cap
- $4.67B
- Enterprise value
- $4.57B
- P/E (TTM)
- 23.6 10-yr median 25.1
- Forward P/E
- 11.2
- PEG ratio
- 1.12
- Price / sales
- 0.8 10-yr median 1.1
- Price / book
- 2.8 10-yr median 3.9
- EV / EBITDA
- 11.1 10-yr median 20.5
- Dividend yield
- —
- Beta
- 0.58
OPCH key metrics, 2016–2025
Fiscal year ended December 31, 2025 · U.S. dollarsOPCH valuation Price multiples at each fiscal year-end price.
OPCH returns How much profit the business earns on the capital it uses.
OPCH per-share figures Results divided by the shares outstanding at year-end.
OPCH financial health Debt, liquidity and how easily interest is covered.
OPCH efficiency & capital use Working capital cycle and where the cash goes.
OPCH valuation history
OPCH returns on capital
Net income (ROE, ROA) or after-tax operating income (ROIC) divided by the average of the opening and closing balance.
OPCH debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease liabilities.
OPCH cash returned to shareholders
OPCH price vs earnings per share
OPCH key metrics
2016–2025| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||
| Market capitalization | $5.20B | $4.01B | $6.08B | $5.48B | $5.15B | $2.83B | $2.33B | $2.28B | $1.80B | $487.4M |
| Enterprise value | $6.25B | $4.82B | $6.90B | $6.34B | $6.12B | $3.87B | $3.57B | $2.77B | $2.24B | $929.8M |
| P/E ratio | 25.1 | 18.9 | 22.8 | 36.4 | 36.8 | — | — | — | — | — |
| Price / sales | 0.9 | 0.8 | 1.4 | 1.4 | 1.5 | 0.9 | 1.0 | 1.2 | 2.2 | 0.5 |
| Price / book | 3.9 | 2.9 | 4.3 | 4.0 | 4.4 | 2.8 | 2.6 | — | — | — |
| Price / free cash flow | 24.0 | 13.9 | 18.4 | 23.6 | 28.2 | 28.2 | 208.7 | — | — | — |
| Price / operating cash flow | 20.1 | 12.4 | 16.4 | 20.5 | 24.7 | 22.2 | 59.1 | — | — | — |
| EV / sales | 1.1 | 1.0 | 1.6 | 1.6 | 1.8 | 1.3 | 1.5 | 1.4 | 2.7 | 1.0 |
| EV / EBITDA | 15.0 | 12.2 | 14.6 | 19.5 | 24.3 | 21.5 | 66.9 | 35.5 | 33.8 | 17.4 |
| EV / free cash flow | 28.8 | 16.7 | 20.9 | 27.3 | 33.4 | 38.5 | 319.6 | — | — | — |
| Earnings yield | 4.0% | 5.3% | 4.4% | 2.7% | 2.7% | −0.3% | −3.3% | −0.3% | −3.6% | −8.8% |
| Free cash flow yield | 4.2% | 7.2% | 5.4% | 4.2% | 3.5% | 3.6% | 0.5% | −1.5% | −0.5% | −9.2% |
| Dividend yield | — | — | — | — | — | 0.0% | 0.1% | — | — | — |
| Shareholder yield (dividends + buybacks) | 6.0% | 6.3% | 4.1% | 0.0% | 0.0% | 0.1% | 0.3% | 0.0% | 0.0% | 0.0% |
| Share price at fiscal year-end | $31.86 | $23.20 | $33.69 | $30.09 | $28.44 | $15.64 | $14.92 | $14.28 | $11.64 | $4.16 |
| Per share | ||||||||||
| Revenue per share | $34.58 | $28.92 | $23.85 | $21.67 | $18.98 | $16.76 | $14.78 | $12.13 | $5.28 | $7.98 |
| Earnings per share | $1.27 | $1.23 | $1.48 | $0.83 | $0.77 | −$0.04 | −$0.49 | −$0.04 | −$0.41 | −$0.36 |
| Operating cash flow per share | $1.58 | $1.87 | $2.06 | $1.47 | $1.15 | $0.70 | $0.25 | −$0.13 | −$0.01 | −$0.30 |
| Free cash flow per share | $1.33 | $1.66 | $1.83 | $1.28 | $1.01 | $0.56 | $0.07 | −$0.21 | −$0.06 | −$0.38 |
| Cash per share | $1.42 | $2.39 | $1.91 | $1.62 | $0.66 | $0.55 | $0.43 | $0.09 | $0.25 | $0.08 |
| Book value per share | $8.12 | $8.12 | $7.88 | $7.61 | $6.49 | $5.61 | $5.80 | −$0.90 | −$0.52 | −$0.27 |
| Tangible book value per share | −$1.85 | −$0.89 | −$2.52 | −$2.81 | −$3.68 | −$4.22 | −$5.79 | −$3.26 | −$3.02 | −$3.66 |
| Dividends per share | — | — | — | — | — | $0.00 | $0.01 | — | — | — |
| Capex per share | $0.25 | $0.21 | $0.23 | $0.19 | $0.14 | $0.15 | $0.18 | $0.09 | $0.05 | $0.08 |
| Debt per share | $7.79 | $7.05 | $6.47 | $6.34 | $5.99 | $6.32 | $8.36 | $3.16 | $3.11 | $3.86 |
| Shares outstanding | 163.4M | 172.8M | 180.4M | 182.1M | 181.2M | 181.0M | 156.3M | 159.9M | 154.7M | 117.2M |
| Change in shares outstanding | −5.5% | −4.2% | −0.9% | +0.5% | +0.1% | +15.8% | −2.3% | +3.4% | +32.1% | +36.4% |
| Returns & profitability | ||||||||||
| Return on equity (ROE) | 15.2% | 15.0% | 19.0% | 11.8% | 12.8% | −0.8% | −19.9% | — | — | — |
| Return on invested capital (ROIC) | 10.8% | 10.8% | 10.4% | 8.0% | 9.1% | 4.2% | −0.0% | 8.6% | −13.0% | −7.6% |
| Return on assets (ROA) | 6.0% | 6.3% | 8.1% | 5.0% | 5.1% | −0.3% | −4.8% | −1.0% | −10.6% | −7.4% |
| Return on tangible assets | 11.4% | 11.4% | 18.4% | 11.3% | 14.8% | −0.9% | −9.8% | −3.0% | −29.3% | −20.3% |
| Free cash flow margin | 3.8% | 5.8% | 7.7% | 5.9% | 5.3% | 3.3% | 0.5% | −1.8% | −1.2% | −4.8% |
| Income quality (OCF / net income) | 1.25 | 1.53 | 1.39 | 1.78 | 1.49 | — | — | — | — | — |
| Financial health | ||||||||||
| Total debt | $1.27B | $1.22B | $1.17B | $1.16B | $1.08B | $1.14B | $1.31B | $504.7M | $480.6M | $451.9M |
| Cash & short-term investments | $232.6M | $412.6M | $343.8M | $294.2M | $119.4M | $99.3M | $67.1M | $14.5M | $39.5M | $9.6M |
| Net debt | $1.04B | $805.4M | $822.6M | $860.8M | $965.6M | $1.04B | $1.24B | $490.1M | $441.1M | $442.4M |
| Debt / equity | 0.96 | 0.87 | 0.82 | 0.83 | 0.92 | 1.13 | 1.44 | — | — | — |
| Debt / assets | 0.37 | 0.36 | 0.35 | 0.36 | 0.39 | 0.43 | 0.50 | 0.86 | 0.79 | 0.74 |
| Net debt / EBITDA | 2.50 | 2.03 | 1.74 | 2.65 | 3.83 | 5.79 | 23.22 | 6.27 | 6.65 | 8.27 |
| Current ratio | 1.53 | 1.70 | 1.77 | 1.76 | 1.55 | 1.51 | 1.69 | 1.63 | 1.79 | 1.35 |
| Quick ratio | 0.96 | 1.20 | 1.33 | 1.36 | 1.15 | 1.15 | 1.34 | 1.38 | 1.44 | 1.07 |
| Interest coverage | 5.3 | 5.3 | 5.1 | 4.4 | 3.4 | 1.2 | -0.0 | 0.8 | -1.2 | -1.0 |
| Working capital | $435.6M | $542.5M | $475.9M | $429.0M | $250.6M | $223.0M | $228.7M | $67.4M | $83.8M | $45.7M |
| Invested capital | $2.37B | $2.21B | $2.24B | $2.25B | $2.14B | $2.06B | $2.15B | $346.1M | $360.0M | $410.8M |
| Tangible asset value | −$302.2M | −$153.0M | −$454.0M | −$511.4M | −$667.7M | −$763.9M | −$904.6M | −$521.7M | −$467.8M | −$428.6M |
| Net current asset value | −$864.4M | −$694.9M | −$812.4M | −$851.9M | −$904.8M | −$974.7M | −$1.12B | −$553.2M | −$497.7M | −$463.3M |
| Graham number | $15.24 | $14.97 | $16.20 | $11.90 | $10.62 | — | — | — | — | — |
| Graham net-net per share | −$7.99 | −$6.38 | −$6.12 | −$6.33 | −$6.35 | −$6.67 | −$8.41 | −$3.84 | −$3.64 | −$4.50 |
| Capital allocation | ||||||||||
| Dividends paid | — | — | — | — | — | $904,000 | $2.0M | — | — | — |
| Share buybacks (net) | $310.0M | $252.7M | $250.3M | $0 | $32,000 | $904,000 | $4.5M | $55,000 | $0 | $0 |
| Dividends + buybacks / free cash flow | 142.7% | 87.8% | 76.0% | 0.0% | 0.0% | 1.8% | 58.2% | — | — | — |
| Capex / revenue | 0.7% | 0.7% | 1.0% | 0.9% | 0.7% | 0.9% | 1.2% | 0.7% | 1.0% | 1.0% |
| Capex / operating cash flow | 16.0% | 11.0% | 11.3% | 13.2% | 12.3% | 21.1% | 71.7% | — | — | — |
| Capex / depreciation | 0.58 | 0.56 | 0.67 | 0.54 | 0.37 | 0.35 | 0.49 | 0.34 | 0.30 | 0.44 |
| Stock-based compensation / revenue | 0.7% | 0.7% | 0.7% | 0.4% | 0.3% | 0.1% | 0.2% | 0.2% | 0.3% | 0.2% |
| SG&A / revenue | 12.1% | 12.6% | 14.1% | 14.4% | 15.3% | 16.5% | 19.9% | 17.8% | 4.8% | 4.1% |
| Efficiency | ||||||||||
| Days sales outstanding | 28.5 | 30.7 | 34.5 | 33.4 | 35.4 | 39.3 | 34.7 | 19.1 | 44.6 | 42.9 |
| Days of inventory on hand | 33.9 | 30.3 | 27.4 | 24.2 | 23.5 | 21.3 | 14.5 | 7.7 | 24.5 | 21.4 |
| Days payables outstanding | 49.3 | 47.5 | 44.3 | 39.0 | 38.6 | 39.1 | 29.3 | 15.0 | 38.8 | 33.7 |
| Cash conversion cycle (days) | 13.1 | 13.5 | 17.6 | 18.5 | 20.2 | 21.5 | 19.9 | 11.8 | 30.2 | 30.7 |
| Receivables turnover | 12.79 | 11.90 | 10.58 | 10.94 | 10.32 | 9.29 | 10.52 | 19.14 | 8.19 | 8.50 |
| Payables turnover | 7.40 | 7.68 | 8.25 | 9.35 | 9.46 | 9.33 | 12.48 | 24.38 | 9.40 | 10.84 |
| Inventory turnover | 10.77 | 12.04 | 13.33 | 15.11 | 15.56 | 17.13 | 25.22 | 47.45 | 14.92 | 17.02 |
| Asset turnover | 1.64 | 1.48 | 1.31 | 1.31 | 1.26 | 1.16 | 1.46 | 3.26 | 1.35 | 1.62 |
| Average receivables | $441.6M | $419.9M | $406.6M | $360.7M | $333.3M | $326.4M | $219.6M | $101.4M | $99.8M | $110.1M |
| Average payables | $625.3M | $518.6M | $402.6M | $329.0M | $281.1M | $252.0M | $144.0M | $62.2M | $58.3M | $62.1M |
| Average inventory | $429.6M | $331.1M | $249.1M | $203.7M | $170.8M | $137.2M | $71.3M | $32.0M | $36.7M | $39.6M |
| Intangibles / total assets | 47.1% | 45.5% | 56.4% | 58.7% | 66.1% | 67.2% | 70.0% | 64.7% | 63.8% | 65.3% |
Computed from OPCH's annual financial statements (latest annual report filed February 24, 2026) and the closing share price on each fiscal year-end, adjusted for stock splits. Figures in U.S. dollars; data from EODHD. Averages use the opening and closing balance of each year.
OPCH valuation and financial ratios
At the end of fiscal 2025 (December 31, 2025), Option Care Health traded at 25.1 times earnings, against a 10-year median of 25.1. Based on the latest twelve months, the trailing P/E is 23.6 and the forward P/E is 11.2. Option Care Health earned a return on equity of 15.2% and a return on invested capital of 10.8% in fiscal 2025. It ended the year with $1.3 billion of debt and $232.6 million in cash and short-term investments, net debt of $1.0 billion. It returned $310.0 million to shareholders: $0 in dividends and $310.0 million in share buybacks, 143% of free cash flow. The share count rose 39.4% from 117.2M to 163.4M over 9 years.
See the OPCH income statement, the OPCH chart for price history, or the OPCH stock overview for the latest quote and news.
OPCH key metrics FAQ
What is Option Care Health's P/E ratio?
Option Care Health's trailing P/E ratio is 23.6 based on the last twelve months of earnings (as of October 18, 2026), and its forward P/E is 11.2. At the end of fiscal 2025 it was 25.1, compared with a 10-year median of 25.1.
What is Option Care Health's EV/EBITDA?
Option Care Health's enterprise value was 15.0 times EBITDA at the end of fiscal 2025 (enterprise value $6.2 billion, EBITDA $416.8 million); the current EV/EBITDA is 11.1.
What is Option Care Health's return on equity?
Option Care Health's return on equity (ROE) was 15.2% in fiscal 2025: net income of $207.6 million on average shareholders' equity of $1.4 billion.
What is Option Care Health's ROIC?
Option Care Health's return on invested capital was 10.8% in fiscal 2025, using after-tax operating income divided by average debt plus equity minus cash.
How much debt does Option Care Health have?
Option Care Health had total debt of $1.3 billion at the end of fiscal 2025, a debt-to-equity ratio of 0.96 and $1.0 billion of net debt (2.50 times EBITDA).
Does Option Care Health buy back its shares?
Yes. Option Care Health spent $310.0 million on net share repurchases in fiscal 2025 Shares outstanding changed −5.5% over the year, to 163.4M..
What is Option Care Health's free cash flow yield?
Option Care Health generated $217.1 million of free cash flow in fiscal 2025, a free cash flow yield of 4.2% on its market value at year-end ($5.2 billion).
What is Option Care Health's current ratio?
Option Care Health's current ratio was 1.53 at the end of fiscal 2025: current assets were 1.53 times current liabilities.